Please wait while the formulary information is being retrieved.
PROCTO-MED HC (HYDROCORTISONE)
- Pruritus of skin
- Skin inflammation
- Proctozone-hc Topical Cream Perineal Applicator
- Proctozone-hc Rectal Cream
- Proctosol Hc Topical Cream Perineal Applicator
- Procto-med Hc Topical Cream Perineal Applicator
- Procto-med Hc Rectal Cream
- Anusol-hc Topical Cream With Perineal Applicator
- By Indication
2.5 % topical cream perineal applicator
- Apply a thin layer to the affected area(s) by topical route 2-4 timesdaily
2.5 % topical cream perineal applicator
- Apply a thin layer to the affected area(s) by topical route 2-4 timesdaily
Proctosol HC 2.5 % topical cream perineal applicator
- Apply a thin layer to the affected area(s) by topical route 2-4 timesdaily
2.5 % topical cream perineal applicator
- Apply a thin layer to the affected area(s) by topical route 2-4 timesdaily
2.5 % topical cream perineal applicator
- Apply a thin layer to the affected area(s) by topical route 2-4 timesdaily
2.5 % topical cream with perineal applicator
- Apply a thin layer to the affected area(s) by topical route 2-4 timesdaily
Pruritus of skin
- Apply a thin layer to the affected area(s) by topical route 2 times per day
- Apply a thin layer to the affected area(s) by topical route 4 times per day
- Apply a thin layer to the affected area(s) by topical route 2-4 timesdaily
Skin inflammation
- Apply a thin layer to the affected area(s) by topical route 2 times per day
- Apply a thin layer to the affected area(s) by topical route 4 times per day
- Apply a thin layer to the affected area(s) by topical route 2-4 timesdaily
- None
Contraindicated
- None
Severe
Moderate
- None
- None
Contraindicated
- None
Severe
Moderate
- Hypothalamic-pituitary insufficiency
PROCTO-MED HC (HYDROCORTISONE)
- Pruritus of skin
- Skin inflammation
- Infection
- Increased appetite
More Frequent
Severe
Less Severe
- Adrenal cortical insufficiency
- Hypercortisolism
- Irregular menstrual periods
- Nausea
Less Frequent
Severe
Less Severe
Rare / Very Rare
Severe
- Abdominal distension
- Abnormal hepatic function tests
- Acute confusion
- Body fluid retention
- Bradycardia
- Cataracts
- Chronic heart failure
- Delirium
- Drug-induced psychosis
- Dyspnea
- Excitement
- Gastrointestinal hemorrhage
- Glaucoma
- Glycosuria
- Hallucinations
- Hepatomegaly
- Hyperglycemia
- Hypertension
- Idiopathic intracranial hypertension
- Impaired wound healing
- Intestinal perforation
- Myopathy
- Ocular hypertension
- Osteoporosis
- Paranoid disorder
- Peptic ulcer
- Personality disorders
- Pulmonary edema
- Thromboembolic disorder
Less Severe
- Acne vulgaris
- Allergic dermatitis
- Depression
- Dizziness
- Euphoria
- Flushing
- Hirsutism
- Insomnia
- Lipodystrophy
- Mood changes
- Nervousness
- Rectal irritation
- Sleep disorder
Contraindicated
None
Severe Precaution
None
Management or Monitoring Precaution
Hydrocortisone (Top,Ophth,Rect)
Prolonged or extensive use may lead to systemic absorption; may affect growth rate.
- 1 Day – 18 Years
- Prolonged or extensive use may lead to systemic absorption; may affect growth rate.
Hydrocortisone (topical, Non-systemic)
- Severity Level:
2
- Additional Notes: Systemic absorption unknown; insuff human data
Contraindicated
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Precaution Exists
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
No Known Risk
Hydrocortisone (top., Rectal)
Insufficient data available; limited use may pose little risk
| General | Excretion Potential | Effect on Infant | Notes |
| No known risks; does not adversely affect lactation | Unknown | Not known; no or inclusive data | Insufficient data available; limited use may pose little risk |
Contraindicated
None
Precaution Exists
None
No Known Risk
None
- None
| Pruritus of skin | |
| L29.8 | Other pruritus |
| L29.9 | Pruritus, unspecified |
| Skin inflammation | |
| L30.8 | Other specified dermatitis |
| L30.9 | Dermatitis, unspecified |
| 0-9 | A-Z |
|---|---|
| L29.8 | Other pruritus |
| L29.9 | Pruritus, unspecified |
| L30.8 | Other specified dermatitis |
| L30.9 | Dermatitis, unspecified |
Formulary Reference Tool